INTERNATIONAL PATENT: AMGEN INC. FILES APPLICATION FOR "ANTI-CD30L ANTIBODIES AND USES THEREOF"

GENEVA, March 25 -- AMGEN INC. (ONE AMGEN CENTER DRIVETHOUSAND OAKS, CA 91320-1799) filed a patent application (PCT/US2024/045966) for "ANTI-CD30L ANTIBODIES AND USES THEREOF" on Sep 10, 2024. With publication no. WO/2025/059023, the details related to the patent application was published on Mar 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): VANDER LUGT, Bryan (c/o Amgen Inc., One Amgen Center DriveLaw Dept-Patent Operations, Mail Stop 28-5-AThousand Oaks, California 91320-1799), HASEGAWA, Haruki (c/o Amgen Inc., One Amgen Center DriveLaw Dept-Patent Operations, Mail Stop 28-5-AThousand...